These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

675 related items for PubMed ID: 19731868

  • 1. [Treatment of diabetes in metabolic syndrome].
    Pelikánova T.
    Vnitr Lek; 2009; 55(7-8):637-45. PubMed ID: 19731868
    [Abstract] [Full Text] [Related]

  • 2. Oral antidiabetic agents: current role in type 2 diabetes mellitus.
    Krentz AJ, Bailey CJ.
    Drugs; 2005; 65(3):385-411. PubMed ID: 15669880
    [Abstract] [Full Text] [Related]

  • 3. Pharmacologic prevention of microvascular and macrovascular complications in diabetes mellitus: implications of the results of recent clinical trials in type 2 diabetes.
    Tandon N, Ali MK, Narayan KM.
    Am J Cardiovasc Drugs; 2012 Feb 01; 12(1):7-22. PubMed ID: 22217193
    [Abstract] [Full Text] [Related]

  • 4. [Identification of factors predicting early evolution of secondary oral hypoglycaemic agent failure and evaluation of clinical standards applied by primary care physicians during qualification to insulin therapy of patients with type 2 diabetes].
    Machoy M.
    Ann Acad Med Stetin; 2004 Feb 01; 50(2):29-39. PubMed ID: 16529163
    [Abstract] [Full Text] [Related]

  • 5. [Cardiovascular risk and cardiometabolic risk: an epidemiological evaluation].
    Vanuzzo D, Pilotto L, Mirolo R, Pirelli S.
    G Ital Cardiol (Rome); 2008 Apr 01; 9(4 Suppl 1):6S-17S. PubMed ID: 18773746
    [Abstract] [Full Text] [Related]

  • 6. Type II diabetes mellitus.
    Edelman SV.
    Adv Intern Med; 1998 Apr 01; 43():449-500. PubMed ID: 9506190
    [Abstract] [Full Text] [Related]

  • 7. [Hypoglycemic therapy in heart disease patients with type 2 diabetes mellitus].
    Cosmi F, Cosmi D.
    G Ital Cardiol (Rome); 2010 Jun 01; 11(6):460-6. PubMed ID: 20922871
    [Abstract] [Full Text] [Related]

  • 8. Metabolic memory: Evolving concepts.
    Misra A, Bloomgarden Z.
    J Diabetes; 2018 Mar 01; 10(3):186-187. PubMed ID: 29091343
    [Abstract] [Full Text] [Related]

  • 9. Insulin therapy in type 2 diabetes.
    Mudaliar S, Edelman SV.
    Endocrinol Metab Clin North Am; 2001 Dec 01; 30(4):935-82. PubMed ID: 11727406
    [Abstract] [Full Text] [Related]

  • 10. Intensive glucose therapy and clinical implications of recent data: a consensus statement from the Global Task Force on Glycaemic Control.
    Akalin S, Berntorp K, Ceriello A, Das AK, Kilpatrick ES, Koblik T, Munichoodappa CS, Pan CY, Rosenthall W, Shestakova M, Wolnik B, Woo V, Yang WY, Yilmaz MT, Global Task Force on Glycaemic Control.
    Int J Clin Pract; 2009 Oct 01; 63(10):1421-5. PubMed ID: 19769698
    [Abstract] [Full Text] [Related]

  • 11. Impact of glycemic treatment choices on cardiovascular complications in type 2 diabetes.
    Weiss IA, Valiquette G, Schwarcz MD.
    Cardiol Rev; 2009 Oct 01; 17(4):165-75. PubMed ID: 19525678
    [Abstract] [Full Text] [Related]

  • 12. Diabetes technology and treatments in the paediatric age group.
    Shalitin S, Peter Chase H.
    Int J Clin Pract Suppl; 2011 Feb 01; (170):76-82. PubMed ID: 21323816
    [Abstract] [Full Text] [Related]

  • 13. Intensive glucose control and cardiovascular outcomes in type 2 diabetes.
    Macisaac RJ, Jerums G.
    Heart Lung Circ; 2011 Oct 01; 20(10):647-54. PubMed ID: 20807681
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Intensive insulin regimens: evidence for benefit.
    Bretzel RG.
    Int J Obes Relat Metab Disord; 2004 Sep 01; 28 Suppl 2():S8-13. PubMed ID: 15306832
    [Abstract] [Full Text] [Related]

  • 16. Thiazolidinediones-benefits on microvascular complications of type 2 diabetes.
    Viberti G.
    J Diabetes Complications; 2005 Sep 01; 19(3):168-77. PubMed ID: 15866064
    [Abstract] [Full Text] [Related]

  • 17. [Type 2 diabetes: what therapeutic strategy?].
    Grimaldi A, Hartemann-Heurtier A.
    Presse Med; 2001 Feb 17; 30(6):288-97. PubMed ID: 11252980
    [Abstract] [Full Text] [Related]

  • 18. Managing type 2 diabetes: going beyond glycemic control.
    Stolar MW, Hoogwerf BJ, Gorshow SM, Boyle PJ, Wales DO.
    J Manag Care Pharm; 2008 Jun 17; 14(5 Suppl B):s2-19. PubMed ID: 18597582
    [Abstract] [Full Text] [Related]

  • 19. Management of type 2 diabetes mellitus in the elderly: special considerations.
    Rosenstock J.
    Drugs Aging; 2001 Jun 17; 18(1):31-44. PubMed ID: 11232737
    [Abstract] [Full Text] [Related]

  • 20. Insulin therapy in type 2 diabetes: what is the evidence?
    van Avendonk MJ, Rutten GE.
    Diabetes Obes Metab; 2009 May 17; 11(5):415-32. PubMed ID: 19175375
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.